STOCK TITAN

Neogen (NEOG) CEO’s son reports small common stock purchases on Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Neogen Corporation filed a Form 4 detailing small stock purchases made in an account held by the CEO’s son. On 01/26/2026, the son purchased 25 shares of common stock at $9.855 per share, and on 02/02/2026, 24 shares at $9.9997 per share. After these trades, that account held 681 shares. The filing states that CEO Nassif Mikheal reports these holdings indirectly and expressly disclaims beneficial ownership of these securities.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nassif Mikheal

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/26/2026 P 25 A $9.855 657 I By son(1)
Common Stock 02/02/2026 P 24 A $9.9997 681 I By son(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Christopher Sefcheck (Attorney in Fact) 02/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for NEOG on this Form 4?

The Form 4 reports two small common stock purchases in an account held by the CEO’s son: 25 shares on January 26, 2026 at $9.855 and 24 shares on February 2, 2026 at $9.9997, bringing that account’s holdings to 681 shares.

Who is the reporting person on this NEOG Form 4 and what is their role?

The reporting person is Nassif Mikheal, who serves as both a director and the CEO of Neogen Corporation. The transactions reported are indirect, in an account identified as held by his son, and the filing includes a disclaimer of beneficial ownership of those securities.

Are the NEOG shares on this Form 4 held directly or indirectly by the CEO?

The shares are reported as held indirectly, described as “By son.” The Form 4 includes a footnote stating that the reporting person disclaims beneficial ownership of these securities, clarifying that the holdings are in the son’s account rather than directly owned by the CEO.

How many NEOG shares did the CEO’s son hold after the reported trades?

After the reported transactions, the account held by the CEO’s son owned 681 shares of Neogen common stock. This reflects the cumulative total following purchases of 25 shares at $9.855 on January 26, 2026 and 24 shares at $9.9997 on February 2, 2026.

What does the beneficial ownership disclaimer mean in this NEOG Form 4?

The Form 4 states that the reporting person disclaims beneficial ownership of the securities held by his son. This means the CEO is not admitting he is the beneficial owner for Section 16 or any other purpose, even though the transactions must still be reported.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

2.23B
215.36M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING